会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Control of cell arrangement
    • 细胞排列控制
    • US5593814A
    • 1997-01-14
    • US308204
    • 1994-09-19
    • Takehisa MatsudaKazuhiko InoueNobutaka Tani
    • Takehisa MatsudaKazuhiko InoueNobutaka Tani
    • C12M3/04C12N5/00C12N5/071G03F7/00G03F7/008G03F7/012
    • G03F7/008C12N5/0068C12N5/069G03F7/00C12N2533/30C12N2533/52C12N2535/10
    • A device for controlling cell arrangement having a pattern composed of a cell adhesive surface and a cell non-adhesive surface, which has a good selectivity of cell adhesion and which can provide a fine pattern of cells in high resolution by culturing cells in a usual manner. The device is prepared by a process which comprises applying a photosensitive, cell adhesive or cell non-adhesive polymer to a surface having a reverse cell adhesivity property to that of the applied polymer, and patternwise irradiating a light to the photosensitive polymer layer followed by development; a process which comprises patternwise irradiating UV or radiation to a cell non-adhesive surface to produce a cell adhesive functional group such as carboxyl group or amino group in the irradiated portion; or a process which comprises patternwise irradiating UV or radiation to a cell adhesive or non-adhesive surface made of plastics to produce a polymerization initiation site in the irradiated portion, and graft-polymerizing at least one monomer having the reverse cell adhesivity property to the plastic surface to produce a polymer on the irradiated portion of plastic surface.
    • 一种用于控制细胞排列的装置,其具有由细胞粘合剂表面和细胞非粘合剂表面组成的图案,其具有良好的细胞粘附选择性,并且可以通过以常规方式培养细胞而以高分辨率提供细胞图案 。 该装置通过一种方法制备,该方法包括将光敏,细胞粘合剂或细胞非粘合性聚合物施加到具有与施加的聚合物相反的反电池粘附性的表面,并将光图案照射到感光性聚合物层,随后显影 ; 包括将UV或辐射图案化地照射到细胞非粘合剂表面以在照射部分中产生诸如羧基或氨基的细胞粘附官能团的方法; 或包括以下步骤:将UV或辐射图案化地照射到由塑料制成的细胞粘合剂或非粘合剂表面,以在照射部分中产生聚合起始部位,并将至少一种具有反电池粘附性的单体接枝聚合到塑料 表面以在塑料表面的照射部分上产生聚合物。
    • 6. 发明申请
    • MODIFIED ERYTHROPOIETIN TO WHICH WATER-SOLUBLE LONG-CHAIN MOLECULE IS ADDED
    • 添加了可溶性长链分子的改良的红细胞膜蛋白
    • US20120264687A1
    • 2012-10-18
    • US13395534
    • 2010-09-15
    • Nobutaka TaniToshihide FujiiHiroyuki WatanabeHirofumi Maeda
    • Nobutaka TaniToshihide FujiiHiroyuki WatanabeHirofumi Maeda
    • A61K38/18A61P7/06
    • A61K9/0019A61K38/1816A61K47/60
    • An object of the invention is to provide a pharmaceutical composition that contains erythropoietin as the active ingredient and has, when administered in humans and/or animals, a hematopoietic effect that lasts for not less than seven days. The invention provides a pharmaceutical composition containing, in an amount equal to not less than 50% of the total erythropoietin, erythropoietin to which two or more water-soluble long-chain molecules are added. The invention also provides a pharmaceutical composition containing erythropoietin to which a water-soluble long-chain molecule is added, wherein the water-soluble long-chain molecule has a molecular weight of not less than 30 kDa. The invention further provides a pharmaceutical composition containing erythropoietin to which a water-soluble long-chain molecule is added, wherein the water-soluble long-chain molecule has a branched chain.
    • 本发明的目的是提供一种含有促红细胞生成素作为活性成分并且在人和/或动物中施用时持续不少于7天的造血作用的药物组合物。 本发明提供一种药物组合物,其含量等于不少于总促红细胞生成素的50%,红细胞生成素,其中加入了两种或更多种水溶性长链分子。 本发明还提供含有促红细胞生成素的药物组合物,其中加入水溶性长链分子,其中水溶性长链分子的分子量不小于30kDa。 本发明还提供含有促红细胞生成素的药物组合物,其中加入水溶性长链分子,其中所述水溶性长链分子具有支链。
    • 8. 发明授权
    • Adsorbent for serum amyloid protein
    • 血清淀粉样蛋白用吸附剂
    • US6037458A
    • 2000-03-14
    • US948470
    • 1992-09-22
    • Fumiyasu HiraiNobutaka Tani
    • Fumiyasu HiraiNobutaka Tani
    • A61M1/34A61M1/36B01D15/00B01J20/32A23J1/00A61K35/14A61M37/00
    • A61M1/3486B01D15/00B01J20/3204B01J20/321B01J20/3212B01J20/3219B01J20/3248B01J20/3251B01J20/3253B01J20/3274B01J20/328A61M1/3679
    • An adsorbent for a serum amyloid protein, which comprises a water-insoluble carrier and either a compound selected from the group consisting of a compound having an anionic functional group, a polyanionic compound having more than one anionic functional groups, aniline and an aniline derivative, said compound being immobilized onto said carrier, or a group of the formula: --NR.sup.1 R.sup.2, wherein R.sup.1 is hydrogen atom, methyl group or ethyl group, and R.sup.2 is an atomic group satisfying that the value of log P, in which P is a distribution coefficient in a water-octanol system, of a compound of the formula: R.sup.2 H is from 0 to 3.2, said group being bonded to said carrier, and a method for removing a serum amyloid protein from body fluid through a removing apparatus using the above adsorbent. According to the present invention, SA proteins, particularly SAA proteins and SAP proteins can be selectively removed from body fluid without decreasing HDL largely. Besides, the adsorbent can be provided at a low cost.
    • 一种血清淀粉样蛋白的吸附剂,其包含水不溶性载体和选自具有阴离子官能团的化合物,具有多于一个阴离子官能团的聚阴离子化合物,苯胺和苯胺衍生物, 所述化合物被固定在所述载体上,或下式-NR 1 R 2基团,其中R 1是氢原子,甲基或乙基,R 2是满足log P值的原子团,其中P是分布 在水 - 辛醇体系中,式R2H的化合物的系数为0至3.2,所述基团键合到所述载体上,以及通过使用上述吸附剂的去除装置从体液中除去血清淀粉样蛋白的方法 。 根据本发明,SA蛋白质,特别是SAA蛋白质和SAP蛋白质可以选择性地从体液中除去而不会大大降低HDL。 此外,可以以低成本提供吸附剂。